JP2023535701A5 - - Google Patents
Info
- Publication number
- JP2023535701A5 JP2023535701A5 JP2023504063A JP2023504063A JP2023535701A5 JP 2023535701 A5 JP2023535701 A5 JP 2023535701A5 JP 2023504063 A JP2023504063 A JP 2023504063A JP 2023504063 A JP2023504063 A JP 2023504063A JP 2023535701 A5 JP2023535701 A5 JP 2023535701A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- optionally substituted
- compound according
- compounds
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025266591A JP2026053472A (ja) | 2020-07-20 | 2025-12-19 | 抗ウイルス剤としての官能化ペプチド |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063054048P | 2020-07-20 | 2020-07-20 | |
| US63/054,048 | 2020-07-20 | ||
| PCT/US2021/042193 WO2022020242A1 (en) | 2020-07-20 | 2021-07-19 | Functionalized peptides as antiviral agents |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025266591A Division JP2026053472A (ja) | 2020-07-20 | 2025-12-19 | 抗ウイルス剤としての官能化ペプチド |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023535701A JP2023535701A (ja) | 2023-08-21 |
| JP2023535701A5 true JP2023535701A5 (enExample) | 2024-07-17 |
| JP7795521B2 JP7795521B2 (ja) | 2026-01-07 |
Family
ID=79729492
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023504063A Active JP7795521B2 (ja) | 2020-07-20 | 2021-07-19 | 抗ウイルス剤としての官能化ペプチド |
| JP2025266591A Pending JP2026053472A (ja) | 2020-07-20 | 2025-12-19 | 抗ウイルス剤としての官能化ペプチド |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025266591A Pending JP2026053472A (ja) | 2020-07-20 | 2025-12-19 | 抗ウイルス剤としての官能化ペプチド |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US20220033383A1 (enExample) |
| EP (2) | EP4635972A3 (enExample) |
| JP (2) | JP7795521B2 (enExample) |
| KR (1) | KR20230069090A (enExample) |
| CN (1) | CN116348477A (enExample) |
| AU (1) | AU2021313130B2 (enExample) |
| BR (1) | BR112022026899A2 (enExample) |
| CA (1) | CA3173964A1 (enExample) |
| CL (1) | CL2023000167A1 (enExample) |
| CO (1) | CO2023000199A2 (enExample) |
| DE (3) | DE202021004113U1 (enExample) |
| ES (2) | ES2922973T3 (enExample) |
| GB (2) | GB2607514B (enExample) |
| HR (1) | HRP20251116T1 (enExample) |
| HU (1) | HUE21846991T1 (enExample) |
| IL (1) | IL300027A (enExample) |
| MX (1) | MX2023000798A (enExample) |
| PL (1) | PL4051265T3 (enExample) |
| RS (1) | RS67201B1 (enExample) |
| SM (1) | SMT202500351T1 (enExample) |
| WO (1) | WO2022020242A1 (enExample) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11124497B1 (en) * | 2020-04-17 | 2021-09-21 | Pardes Biosciences, Inc. | Inhibitors of cysteine proteases and methods of use thereof |
| US11174231B1 (en) | 2020-06-09 | 2021-11-16 | Pardes Biosciences, Inc. | Inhibitors of cysteine proteases and methods of use thereof |
| BR112022025037A2 (pt) * | 2020-06-10 | 2023-02-14 | Aligos Therapeutics Inc | Compostos antivirais para tratar infecções por coronavírus, picornavírus e norovírus |
| EP4178955A1 (en) | 2020-07-11 | 2023-05-17 | Pfizer Inc. | Antiviral heteroaryl ketone derivatives |
| US11351149B2 (en) | 2020-09-03 | 2022-06-07 | Pfizer Inc. | Nitrile-containing antiviral compounds |
| US12540141B2 (en) | 2020-11-23 | 2026-02-03 | Enanta Pharmaceuticals, Inc. | Spiropyrrolidine derived antiviral agents |
| WO2022109360A1 (en) | 2020-11-23 | 2022-05-27 | Enanta Pharmaceuticals, Inc. | Novel spiropyrrolidine derived antiviral agents |
| RS66213B1 (sr) * | 2021-04-16 | 2024-12-31 | Fujian Akeylink Biotechnology Co Ltd | Jedinjenje kratkog peptida prolina modifikovanog prstenom i upotreba istog |
| US11970502B2 (en) | 2021-05-04 | 2024-04-30 | Enanta Pharmaceuticals, Inc. | Macrocyclic antiviral agents |
| US12398147B2 (en) | 2021-05-11 | 2025-08-26 | Enanta Pharmaceuticals, Inc. | Macrocyclic spiropyrrolidine derived antiviral agents |
| WO2022251615A1 (en) | 2021-05-28 | 2022-12-01 | Arun K Ghosh | Compounds for the treatment of sars |
| WO2022266363A1 (en) * | 2021-06-16 | 2022-12-22 | The Scripps Research Institute | Protease inhibitors for the treatment of coronavirus infections |
| WO2023283256A1 (en) | 2021-07-09 | 2023-01-12 | Aligos Therapeutics, Inc. | Anti-viral compounds |
| US12643905B2 (en) | 2021-07-23 | 2026-06-02 | Enanta Pharmaceuticals, Inc. | Spiropyrrolidine derived antiviral agents |
| US12479854B2 (en) | 2021-07-29 | 2025-11-25 | Enanta Pharmaceuticals, Inc. | Spiropyrrolidine derived antiviral agents |
| US12065428B2 (en) | 2021-09-17 | 2024-08-20 | Aligos Therapeutics, Inc. | Anti-viral compounds |
| WO2023086352A1 (en) | 2021-11-12 | 2023-05-19 | Enanta Pharmaceuticals, Inc. | Novel spiropyrrolidine derived antiviral agents |
| US11858945B2 (en) | 2021-11-12 | 2024-01-02 | Enanta Pharmaceuticals, Inc. | Alkyne-containing antiviral agents |
| WO2023086400A1 (en) | 2021-11-12 | 2023-05-19 | Enanta Pharmaceuticals, Inc. | Novel spiropyrrolidine derived antiviral agents |
| WO2023088418A1 (en) * | 2021-11-20 | 2023-05-25 | Fochon Biosciences, Ltd. | Compounds as sars-cov-2 inhibitors |
| WO2023107417A1 (en) | 2021-12-08 | 2023-06-15 | Enanta Pharmaceuticals, Inc. | Heterocyclic antiviral agents |
| US11993600B2 (en) | 2021-12-08 | 2024-05-28 | Enanta Pharmaceuticals, Inc. | Saturated spirocyclics as antiviral agents |
| WO2023116811A1 (zh) * | 2021-12-22 | 2023-06-29 | 福建广生中霖生物科技有限公司 | 含β-胺基酮的短肽化合物及其应用 |
| TW202334123A (zh) * | 2021-12-31 | 2023-09-01 | 大陸商蘇州愛科百發生物醫藥技術有限公司 | 用於預防和治療冠狀病毒感染的化合物及其偶聯物和方法 |
| US12006291B2 (en) | 2022-01-11 | 2024-06-11 | Enanta Pharmaceuticals, Inc. | Processes for the preparation of 4,6,7-trifluoro-1H-indole-2-carboxylic acid |
| WO2023134730A1 (zh) * | 2022-01-13 | 2023-07-20 | 先声再明医药有限公司 | 一种酰胺类抗病毒化合物 |
| US11760722B2 (en) | 2022-01-18 | 2023-09-19 | Ascletis Bioscience Co., Ltd. | Inhibitors of cysteine proteases and methods of use thereof |
| CN114230504B (zh) * | 2022-02-24 | 2022-06-03 | 南京桦冠生物技术有限公司 | 一种吡咯烷酮中间体的合成方法 |
| CN116768967A (zh) * | 2022-03-07 | 2023-09-19 | 广州谷森制药有限公司 | 氘代内酰胺类化合物及其制备方法、组合物和用途 |
| CN117143082B (zh) * | 2022-03-07 | 2026-07-03 | 广州国家实验室 | 用作3c样蛋白酶抑制剂的氮杂双环[3.1.0]己烷衍生物 |
| CN114957383B (zh) * | 2022-04-01 | 2024-12-31 | 中国科学院上海药物研究所 | 一种拟肽类化合物及其制备方法、药物组合物和用途 |
| US12145942B2 (en) | 2022-04-05 | 2024-11-19 | Enanta Pharmaceuticals, Inc. | Spiropyrrolidine derived antiviral agents |
| CN117164582A (zh) * | 2022-05-31 | 2023-12-05 | 周龙兴 | 一种蛋白酶抑制剂及其药物组合物和用途 |
| CN117362213B (zh) * | 2022-06-30 | 2026-07-07 | 武汉瑞晟药业有限公司 | 一种吡咯烷酮中间体的制备方法 |
| AU2023303408A1 (en) | 2022-07-06 | 2024-12-19 | Aligos Therapeutics, Inc. | Anti-viral compounds |
| WO2024059087A1 (en) * | 2022-09-13 | 2024-03-21 | Takeda Pharmaceutical Company Limited | 3-(1h-indole-2-carbonyl)-6,6-dimethyl-n-((s)-1-oxo-3-((s)-2-oxopyrrolidin-3-yl)p ropan-2-yl)-3-azabicyclo[3.1.0]hexane-2-carboxamide derivatives as mpro inhibitors for the treatment of coronavirus infections |
| WO2024107778A1 (en) * | 2022-11-15 | 2024-05-23 | Takeda Pharmaceutical Company Limited | Novel protease inhibitors for treatment of coronavirus infections |
| GEAP202516786A (en) * | 2022-11-22 | 2025-09-25 | Merck Sharp & Dohme Llc | 2-amino-n-(4-amino-3,4-dioxo-1-(2-oxopyrrolidin-3-yl)butan-2-yl)benzamide derivatives as protease inhibitors for treating or preventing coronavirus infection |
| EP4501942A1 (en) | 2023-08-02 | 2025-02-05 | Consejo Superior De Investigaciones Científicas (CSIC) | Peptidomimetics with antiviral activity |
| WO2025125695A2 (en) | 2024-12-17 | 2025-06-19 | Medchemica Consultancy Ltd | Chemical compoundsid50000167790940 p. doc 2025-05-07 filing no.:19 |
Family Cites Families (66)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5508269A (en) | 1994-10-19 | 1996-04-16 | Pathogenesis Corporation | Aminoglycoside formulation for aerosolization |
| US6083922A (en) | 1996-04-02 | 2000-07-04 | Pathogenesis, Corp. | Method and a tobramycin aerosol formulation for treatment prevention and containment of tuberculosis |
| US5767068A (en) | 1997-02-13 | 1998-06-16 | Pathogenesis Corporation | Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections |
| US7012066B2 (en) * | 2000-07-21 | 2006-03-14 | Schering Corporation | Peptides as NS3-serine protease inhibitors of hepatitis C virus |
| US7504382B2 (en) | 2003-05-06 | 2009-03-17 | Cytovia, Inc. | Protease inhibitors for coronaviruses and SARS-CoV and the use thereof |
| DE602004011047T2 (de) | 2003-05-13 | 2008-12-24 | Universität Zu Lübeck | Kristallstruktur von der humanen coronavirus 229e hauptproteinase und deren verwendung zur entwicklung von sars-inhibitoren |
| US20060014821A1 (en) * | 2003-08-27 | 2006-01-19 | Agouron Pharmaceuticals, Inc. | Inhibitors of SARS 3C like protease |
| US7462594B2 (en) | 2003-12-31 | 2008-12-09 | Taigen Biotechnology Co., Ltd. | Peptide-like compounds that inhibit coronaviral 3CL and flaviviridae viral proteases |
| WO2005113580A1 (en) * | 2004-05-21 | 2005-12-01 | Pfizer Inc. | Anticoronviral compounds and compositions, their pharmaceutical uses and materials for their synthesis |
| WO2006061714A2 (en) | 2004-12-09 | 2006-06-15 | Pfizer Inc. | Anticoronaviral compounds and compositions, their pharmaceutical uses and materials for their synthesis |
| EP1783228A1 (en) | 2005-11-08 | 2007-05-09 | ETH Zürich | Recombinant expression of multiprotein complexes using polygenes |
| WO2007081447A2 (en) | 2005-11-22 | 2007-07-19 | Novartis Vaccines And Diagnostics, Inc. | Norovirus and sapovirus antigens |
| ES2372709T3 (es) | 2006-07-05 | 2012-01-25 | Catalyst Biosciences, Inc. | Procedimientos de cribado de proteasas y proteasas identificadas por los mismos. |
| CN105925535A (zh) | 2009-06-05 | 2016-09-07 | 细胞动力国际有限公司 | 重编程t细胞和造血细胞的方法 |
| US9008723B2 (en) * | 2010-01-08 | 2015-04-14 | United States Foundation For Inspiration And Recognition Of Science And Technology | Wireless adapter |
| CA2802249A1 (en) | 2010-06-15 | 2011-12-22 | Cellular Dynamics International, Inc. | Generation of induced pluripotent stem cells from small volumes of peripheral blood |
| CA2850003C (en) | 2011-09-27 | 2020-01-07 | Kansas State University Research Foundation | Broad-spectrum antivirals against 3c or 3c-like proteases of picornavirus-like supercluster: picornaviruses, caliciviruses and coronaviruses |
| CN104220461A (zh) | 2011-12-29 | 2014-12-17 | Atyr医药公司 | 天冬氨酰-tRNA合成酶-FC缀合物 |
| US9828342B2 (en) | 2012-02-24 | 2017-11-28 | City Of Hope | Isatin derivatives, pharmaceutical compositions thereof, and methods of use thereof |
| CA2872147A1 (en) | 2012-05-02 | 2013-11-07 | Kansas State University Research Foundation | Macrocyclic and peptidomimetic compounds as broad-spectrum antivirals against 3c or 3c-like proteases of picornaviruses, caliciviruses and coronaviruses |
| US9791436B2 (en) | 2012-09-12 | 2017-10-17 | The University Of Queensland | Protease-based biosensor |
| AU2014205122B2 (en) | 2013-01-11 | 2017-11-02 | Impossible Foods Inc. | Non-dairy cheese replica comprising a coacervate |
| US20160068820A9 (en) | 2013-02-08 | 2016-03-10 | The United States Of America, As Represented By The Secretary Of Agriculture | Novel Nylanderia Pubens Virus |
| CN114717206A (zh) | 2013-03-15 | 2022-07-08 | Atyr 医药公司 | 组氨酰-trna合成酶-fc缀合物 |
| EP3027204B1 (en) | 2013-07-29 | 2022-01-05 | 2seventy bio, Inc. | Multipartite signaling proteins and uses thereof |
| WO2015035452A1 (en) | 2013-09-12 | 2015-03-19 | The University Of Queensland | Bimolecular protease-based biosensor |
| GB201320351D0 (en) | 2013-11-18 | 2014-01-01 | Erasmus Universiteit Medisch Ct | Method |
| WO2015164759A2 (en) | 2014-04-25 | 2015-10-29 | Bluebird Bio, Inc. | Mnd promoter chimeric antigen receptors |
| US10023879B2 (en) | 2014-06-04 | 2018-07-17 | Fate Therapeutics, Inc. | Minimal volume reprogramming of mononuclear cells |
| RS61406B1 (sr) | 2014-06-06 | 2021-03-31 | Bluebird Bio Inc | Poboljšane kompozicije t ćelija |
| US10017463B2 (en) | 2014-07-21 | 2018-07-10 | Brandeis University | Inhibitors of deubiquitinating proteases |
| GB201413020D0 (en) | 2014-07-23 | 2014-09-03 | Pribright The Inst | Coronavirus |
| US9328147B2 (en) | 2014-09-05 | 2016-05-03 | Chung Yuan Christian University | Recombinant baculovirus vector and uses thereof |
| US10383929B2 (en) | 2014-12-12 | 2019-08-20 | Bluebird Bio, Inc. | BCMA chimeric antigen receptors |
| CA2977980C (en) | 2015-02-27 | 2022-04-26 | Iowa State University Research Foundation, Inc. | Porcine epidemic diarrhea virus strains and immunogenic compositions therefrom |
| US10784994B2 (en) | 2015-08-21 | 2020-09-22 | Lg Electronics Inc. | Method for transmitting information for LTE-WLAN aggregation system and a device therefor |
| US11058779B2 (en) | 2015-09-08 | 2021-07-13 | Sirnaomics, Inc. | Sirna/nanoparticle formulations for treatment of middle-east respiratory syndrome coronaviral infection |
| WO2017156071A1 (en) | 2016-03-09 | 2017-09-14 | Blade Therapeutics, Inc. | Cyclic keto-amide compounds as calpain modulators and methods of production and use thereof |
| US9975885B2 (en) | 2016-04-28 | 2018-05-22 | Purdue Research Foundation | Broad-spectrum non-covalent coronavirus protease inhibitors |
| US11021513B2 (en) | 2016-05-13 | 2021-06-01 | Emory University | Peptidomimetics for the treatment of norovirus infection |
| US11013779B2 (en) | 2016-06-20 | 2021-05-25 | Kansas State University Research Foundation | Small molecule therapeutic inhibitors against picornaviruses, caliciviruses, and coronaviruses |
| WO2018023054A1 (en) | 2016-07-28 | 2018-02-01 | Kansas State University Research Foundation | Protease transition state inhibitor prodrugs |
| UY37381A (es) * | 2016-08-30 | 2018-03-23 | Glaxosmithkline Ip No 2 Ltd | Compuestos que inhiben proteasas 3c y 3cl y métodos de uso de los mismos |
| US10934261B2 (en) | 2016-09-28 | 2021-03-02 | Blade Therapeutics, Inc. | Calpain modulators and therapeutic uses thereof |
| IL270776B2 (en) | 2017-05-25 | 2024-11-01 | Bluebird Bio Inc | Cblb endonuclease variants, compositions, and methods of use |
| WO2020072059A1 (en) | 2018-10-04 | 2020-04-09 | Bluebird Bio, Inc. | Cblb endonuclease variants, compositions, and methods of use |
| AU2020289560A1 (en) | 2019-06-05 | 2021-12-23 | Emory University | Peptidomimetics for the treatment of coronavirus and picornavirus infections |
| US11045546B1 (en) | 2020-03-30 | 2021-06-29 | Cytodyn Inc. | Methods of treating coronavirus infection |
| US12485157B2 (en) | 2020-04-05 | 2025-12-02 | Pfizer Inc. | Method of treating COVID-19 |
| WO2021207409A2 (en) | 2020-04-08 | 2021-10-14 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Small molecule inhibitors of sars-cov-2 viral replication and uses thereof |
| WO2021206877A1 (en) | 2020-04-10 | 2021-10-14 | Cocrystal Pharma, Inc. | Inhibitors of norovirus and coronavirus replication |
| IL297069A (en) | 2020-04-10 | 2022-12-01 | Cocrystal Pharma Inc | Replication inhibitors of norovirus and corona virus |
| US11124497B1 (en) | 2020-04-17 | 2021-09-21 | Pardes Biosciences, Inc. | Inhibitors of cysteine proteases and methods of use thereof |
| CA3180177A1 (en) * | 2020-05-08 | 2021-11-11 | The Board Of Trustees Of The Leland Stanford Junior University | Protease inhibitors for treatment or prevention of coronavirus disease |
| US11174231B1 (en) | 2020-06-09 | 2021-11-16 | Pardes Biosciences, Inc. | Inhibitors of cysteine proteases and methods of use thereof |
| GB2595975B (en) * | 2020-06-09 | 2022-12-07 | Pardes Biosciences Inc | Inhibitors of cysteine proteases and methods of use thereof |
| BR112022025037A2 (pt) * | 2020-06-10 | 2023-02-14 | Aligos Therapeutics Inc | Compostos antivirais para tratar infecções por coronavírus, picornavírus e norovírus |
| EP4178955A1 (en) * | 2020-07-11 | 2023-05-17 | Pfizer Inc. | Antiviral heteroaryl ketone derivatives |
| US10959969B1 (en) | 2020-07-24 | 2021-03-30 | Lanny L Johnson | Methods of treating SARS Cov-2 virus with protocatechuic acid |
| WO2022020711A1 (en) | 2020-07-24 | 2022-01-27 | The Texas A&M University System | Sars-cov-2 main protease inhibitors |
| CN115960088B (zh) * | 2020-07-31 | 2024-07-26 | 四川大学 | 一种新型冠状病毒主蛋白酶的抑制剂及其制备方法和用途 |
| US11351149B2 (en) | 2020-09-03 | 2022-06-07 | Pfizer Inc. | Nitrile-containing antiviral compounds |
| RS66213B1 (sr) * | 2021-04-16 | 2024-12-31 | Fujian Akeylink Biotechnology Co Ltd | Jedinjenje kratkog peptida prolina modifikovanog prstenom i upotreba istog |
| WO2022251615A1 (en) * | 2021-05-28 | 2022-12-01 | Arun K Ghosh | Compounds for the treatment of sars |
| JP2024522990A (ja) * | 2021-06-02 | 2024-06-25 | エイシア セラピューティクス， インコーポレイテッド | 抗ウイルス薬としてのプロテアーゼ阻害剤 |
| WO2023286844A1 (ja) * | 2021-07-15 | 2023-01-19 | 国立研究開発法人国立国際医療研究センター | 抗ウイルス活性等の生理活性を有する化合物 |
-
2021
- 2021-07-19 EP EP25185114.3A patent/EP4635972A3/en active Pending
- 2021-07-19 MX MX2023000798A patent/MX2023000798A/es unknown
- 2021-07-19 JP JP2023504063A patent/JP7795521B2/ja active Active
- 2021-07-19 ES ES21846991T patent/ES2922973T3/es active Active
- 2021-07-19 DE DE202021004113.3U patent/DE202021004113U1/de active Active
- 2021-07-19 SM SM20250351T patent/SMT202500351T1/it unknown
- 2021-07-19 HR HRP20251116TT patent/HRP20251116T1/hr unknown
- 2021-07-19 RS RS20250906A patent/RS67201B1/sr unknown
- 2021-07-19 AU AU2021313130A patent/AU2021313130B2/en active Active
- 2021-07-19 IL IL300027A patent/IL300027A/en unknown
- 2021-07-19 EP EP21846991.4A patent/EP4051265B1/en active Active
- 2021-07-19 ES ES202290062A patent/ES2936277B2/es active Active
- 2021-07-19 KR KR1020237005438A patent/KR20230069090A/ko active Pending
- 2021-07-19 WO PCT/US2021/042193 patent/WO2022020242A1/en not_active Ceased
- 2021-07-19 PL PL21846991.4T patent/PL4051265T3/pl unknown
- 2021-07-19 DE DE21846991.4T patent/DE21846991T1/de active Pending
- 2021-07-19 US US17/379,409 patent/US20220033383A1/en not_active Abandoned
- 2021-07-19 CN CN202180059223.3A patent/CN116348477A/zh active Pending
- 2021-07-19 DE DE112021000413.1T patent/DE112021000413B4/de active Active
- 2021-07-19 HU HUE21846991A patent/HUE21846991T1/hu unknown
- 2021-07-19 GB GB2211934.1A patent/GB2607514B/en active Active
- 2021-07-19 CA CA3173964A patent/CA3173964A1/en active Pending
- 2021-07-19 GB GB2306834.9A patent/GB2619610B/en active Active
- 2021-07-19 BR BR112022026899A patent/BR112022026899A2/pt not_active Application Discontinuation
- 2021-10-21 US US17/506,981 patent/US20220041652A1/en not_active Abandoned
- 2021-11-09 US US17/522,176 patent/US11358953B2/en active Active
-
2023
- 2023-01-11 CO CONC2023/0000199A patent/CO2023000199A2/es unknown
- 2023-01-18 CL CL2023000167A patent/CL2023000167A1/es unknown
-
2025
- 2025-12-19 JP JP2025266591A patent/JP2026053472A/ja active Pending